EA200200972A1 - Кристаллическое основание циталопрама - Google Patents

Кристаллическое основание циталопрама

Info

Publication number
EA200200972A1
EA200200972A1 EA200200972A EA200200972A EA200200972A1 EA 200200972 A1 EA200200972 A1 EA 200200972A1 EA 200200972 A EA200200972 A EA 200200972A EA 200200972 A EA200200972 A EA 200200972A EA 200200972 A1 EA200200972 A1 EA 200200972A1
Authority
EA
Eurasian Patent Office
Prior art keywords
salts
base
cytalogue
citalopram
preparations
Prior art date
Application number
EA200200972A
Other languages
English (en)
Inventor
Ханс Петерсен
Клаус Петер Бегесе
Пер Хольм
Original Assignee
Х.Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8159320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200200972(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х.Лундбекк А/С filed Critical Х.Лундбекк А/С
Publication of EA200200972A1 publication Critical patent/EA200200972A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Laminated Bodies (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Данное изобретение относится к кристаллическому основанию хорошо известного антидепрессантного лекарственного средства циталопрама, 1-[3-(диметиламино)пропил]-1-(4-фторфенил)-1,3-дигидро-5-изобензофуранкарбонитрилу, препаратам с указанным основанием, способу получения очищенных солей циталопрама, таких как гидробромид, с использованием основания, солям, полученным указанным способом, и препаратам, содержащим указанные соли.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200972A 2000-03-13 2001-02-28 Кристаллическое основание циталопрама EA200200972A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200000402 2000-03-13
DKPCT/DK00/00183 2000-04-13
PCT/DK2001/000137 WO2001068627A1 (en) 2000-03-13 2001-02-28 Crystalline base of citalopram

Publications (1)

Publication Number Publication Date
EA200200972A1 true EA200200972A1 (ru) 2003-02-27

Family

ID=8159320

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200972A EA200200972A1 (ru) 2000-03-13 2001-02-28 Кристаллическое основание циталопрама

Country Status (42)

Country Link
US (7) US20010031784A1 (ru)
EP (2) EP1227088B1 (ru)
JP (1) JP2003527383A (ru)
KR (1) KR20020080486A (ru)
CN (2) CN1680350A (ru)
AR (1) AR029811A1 (ru)
AT (3) ATE223396T1 (ru)
AU (2) AU746664B2 (ru)
BE (1) BE1013210A3 (ru)
BG (1) BG107065A (ru)
BR (1) BR0109373A (ru)
CA (2) CA2411732A1 (ru)
CH (2) CH691537A5 (ru)
CZ (1) CZ292077B6 (ru)
DE (7) DE20007303U1 (ru)
DK (3) DK173903B1 (ru)
EA (1) EA200200972A1 (ru)
ES (3) ES2173054T3 (ru)
FI (2) FI20010156A0 (ru)
FR (1) FR2806086B1 (ru)
GB (2) GB2357762B (ru)
GR (1) GR1003796B (ru)
HK (1) HK1054750A1 (ru)
HR (1) HRP20020756A2 (ru)
HU (3) HU0001581D0 (ru)
IE (1) IES20010109A2 (ru)
IL (2) IL158072A0 (ru)
IS (1) IS5841A (ru)
IT (2) IT1319645B1 (ru)
MX (1) MXPA02008793A (ru)
NL (2) NL1016435C1 (ru)
NO (2) NO312031B1 (ru)
PL (1) PL360158A1 (ru)
PT (2) PT1169314E (ru)
SE (2) SE517136C2 (ru)
SI (2) SI1227088T1 (ru)
SK (1) SK285528B6 (ru)
TR (1) TR200202185T2 (ru)
UA (1) UA74360C2 (ru)
WO (1) WO2001068627A1 (ru)
YU (1) YU68802A (ru)
ZA (1) ZA200207148B (ru)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9917346A (pt) 1999-04-14 2002-02-26 Lundbeck & Co As H Método para preparação de citalopram intermadiário e utilização do mesmo
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US7887556B2 (en) 2000-12-20 2011-02-15 Fox Hollow Technologies, Inc. Debulking catheters and methods
US6299622B1 (en) 1999-08-19 2001-10-09 Fox Hollow Technologies, Inc. Atherectomy catheter with aligned imager
US7708749B2 (en) 2000-12-20 2010-05-04 Fox Hollow Technologies, Inc. Debulking catheters and methods
US7713279B2 (en) 2000-12-20 2010-05-11 Fox Hollow Technologies, Inc. Method and devices for cutting tissue
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
GB2376233B (en) * 2000-08-10 2003-09-10 Lundbeck & Co As H Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns
WO2002049690A2 (en) 2000-12-20 2002-06-27 Fox Hollow Technologies, Inc. Debulking catheter
WO2001045483A2 (en) * 2000-12-22 2001-06-28 H. Lundbeck A/S Method for the preparation of pure citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
MEP5908A (xx) * 2001-05-01 2010-02-10 Lundbeck & Co As H Upotreba enantiomerno čistog escitaloprama
AU2002355624B2 (en) 2001-07-31 2006-02-02 H. Lundbeck A/S Crystalline composition containing escitalopram
AU2003222435A1 (en) * 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
GB2386119A (en) * 2002-02-27 2003-09-10 Cipla Ltd Purification of citalopram
GB2387844B (en) * 2002-02-27 2005-05-11 Matrix Lab Ltd Separation of impurities from a crude mixture of citalopram
GB2386118A (en) * 2002-02-27 2003-09-10 Cipla Ltd Citalopram
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
GB2385848A (en) * 2002-02-27 2003-09-03 Cipla Ltd Citalopram salts
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
EP1346989A1 (en) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Improved process for the preparation of citalopram and its hydrobromide
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
WO2004085416A1 (en) * 2003-03-24 2004-10-07 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
AU2003238676A1 (en) * 2003-04-21 2004-11-19 Podile Khadgapathi An improved process for the preparation of citalopram hydrobromide
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
EP1486492A3 (en) * 2003-06-10 2005-02-23 Sun Pharmaceuticals Industries Ltd. A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
GB0317475D0 (en) 2003-07-25 2003-08-27 Meditab Specialities Pvt Ltd Product
JP4025735B2 (ja) * 2003-08-21 2007-12-26 ローム アンド ハース カンパニー 水性系を処理する方法
GB0320312D0 (en) 2003-08-29 2003-10-01 Novartis Ag Purification process
CN100569765C (zh) 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
ITTO20050301A1 (it) * 2005-05-05 2006-11-06 Errekappa Euroterapici Spa Formulazioni liquide orali contenenti citalopram
WO2006123243A2 (en) * 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
KR101306635B1 (ko) 2005-06-27 2013-10-11 밸리언트 인터내셔널(바베이도스) 에스알엘 부프로피온염의 개질-방출 제형
US20070276419A1 (en) 2006-05-26 2007-11-29 Fox Hollow Technologies, Inc. Methods and devices for rotating an active element and an energy emitter on a catheter
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
RU2503422C2 (ru) 2008-10-13 2014-01-10 ТАЙКО ХЕЛСКЕА ГРУП эЛПи Устройства и способы манипулирования стержнем катетера
WO2010126882A1 (en) 2009-04-29 2010-11-04 Fox Hollow Technologies, Inc. Methods and devices for cutting and abrading tissue
KR101323514B1 (ko) 2009-05-14 2013-10-29 코비디엔 엘피 세척이 용이한 죽상반 절제 카테터 및 사용 방법
RU2526915C2 (ru) 2009-12-02 2014-08-27 ТАЙКО ХЕЛСКЕА ГРУП эЛПи Способы и устройства для срезания ткани
CA2783301C (en) 2009-12-11 2015-02-24 Tyco Healthcare Group Lp Material removal device having improved material capture efficiency and methods of use
WO2011159697A1 (en) 2010-06-14 2011-12-22 Tyco Healthcare Group Lp Material removal device
CA2815186C (en) 2010-10-28 2015-12-29 Covidien Lp Material removal device and method of use
CA2817213C (en) 2010-11-11 2016-06-14 Covidien Lp Flexible debulking catheters with imaging and methods of use and manufacture
US8992717B2 (en) 2011-09-01 2015-03-31 Covidien Lp Catheter with helical drive shaft and methods of manufacture
US9532844B2 (en) 2012-09-13 2017-01-03 Covidien Lp Cleaning device for medical instrument and method of use
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
WO2015200702A1 (en) 2014-06-27 2015-12-30 Covidien Lp Cleaning device for catheter and catheter including the same
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
WO2021016112A2 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2233970A (en) * 1941-03-04 Quinoline compound and process of
US2584429A (en) * 1950-12-29 1952-02-05 Rohm & Haas 1,1-diphenyl-4-tert.-amino-2-butyne-1-ols
GB1143702A (ru) * 1965-03-18
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
DK213290D0 (da) 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
DE1015416T1 (de) * 1997-07-08 2000-10-05 H. Lundbeck A/S, Kobenhavn-Valby Verfahren zur herstellung von citalopram
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
EA002770B1 (ru) * 1997-11-11 2002-08-29 Х.Лундбекк А/С Способ получения циталопрама
JP3892667B2 (ja) * 1998-10-20 2007-03-14 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
BR9917346A (pt) 1999-04-14 2002-02-26 Lundbeck & Co As H Método para preparação de citalopram intermadiário e utilização do mesmo
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
US6433196B1 (en) * 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof

Also Published As

Publication number Publication date
IL147339A (en) 2004-09-27
HK1054750A1 (en) 2003-12-12
US20040167210A1 (en) 2004-08-26
AU2001100197A4 (en) 2001-09-20
IT1319645B1 (it) 2003-10-23
SI1169314T1 (en) 2002-12-31
JP2003527383A (ja) 2003-09-16
DE20121240U1 (de) 2002-07-04
SI1227088T1 (en) 2003-12-31
IL158072A0 (en) 2004-03-28
DE1227088T1 (de) 2003-02-06
US20030078442A1 (en) 2003-04-24
AR029811A1 (es) 2003-07-16
EP1169314A1 (en) 2002-01-09
CA2360287A1 (en) 2001-09-20
CH691477A5 (de) 2001-07-31
PT1227088E (pt) 2003-12-31
US20040132808A1 (en) 2004-07-08
BG107065A (bg) 2003-05-30
KR20020080486A (ko) 2002-10-23
NL1016435C1 (nl) 2000-11-06
ES2180471T1 (es) 2003-02-16
FR2806086B1 (fr) 2003-05-09
AU3725201A (en) 2001-09-13
DE60100786T2 (de) 2004-07-15
DE60100022D1 (de) 2002-10-10
ES2180471T3 (es) 2004-05-01
ES2159491A1 (es) 2001-10-01
SI1169314T2 (sl) 2011-08-31
DE20007303U1 (de) 2000-07-27
US20050165244A1 (en) 2005-07-28
NO20010619D0 (no) 2001-02-06
NO20010619L (no) 2001-09-14
ITMI20010406A1 (it) 2002-08-28
UA74360C2 (ru) 2005-12-15
US20050165092A1 (en) 2005-07-28
HU0100450D0 (en) 2001-04-28
DE10108042A1 (de) 2001-10-18
HU0001581D0 (en) 2000-06-28
ZA200207148B (en) 2003-04-23
DE10164687B4 (de) 2006-04-27
YU68802A (sh) 2005-11-28
ATE223396T1 (de) 2002-09-15
GR1003796B (el) 2002-02-08
SE0200730L (sv) 2002-08-29
CN1258530C (zh) 2006-06-07
HU0100531D0 (en) 2001-03-28
MXPA02008793A (es) 2003-02-12
NO315851B1 (no) 2003-11-03
WO2001068627A1 (en) 2001-09-20
ES2173054T3 (es) 2002-12-16
DE60100022T2 (de) 2003-03-06
EP1227088B1 (en) 2003-09-17
ITMI20002425A1 (it) 2002-05-09
AT4364U1 (de) 2001-06-25
BE1013210A3 (fr) 2001-10-02
CZ2001808A3 (cs) 2002-01-16
NO312031B1 (no) 2002-03-04
NO20020356D0 (no) 2002-01-23
NL1017413C1 (nl) 2001-09-13
FR2806086A1 (fr) 2001-09-14
ES2173054T1 (es) 2002-10-16
DK1169314T3 (da) 2002-10-14
DK173903B1 (da) 2002-02-11
AU2001100197B4 (en) 2001-12-06
HUP0100531A3 (en) 2004-04-28
IL147339A0 (en) 2002-08-14
SK13132002A3 (sk) 2003-01-09
US20010031784A1 (en) 2001-10-18
FI20010156A0 (fi) 2001-01-25
BR0109373A (pt) 2002-12-24
HUP0100531A2 (hu) 2002-01-28
DE60100786D1 (de) 2003-10-23
ATE250050T1 (de) 2003-10-15
GB2357762A (en) 2001-07-04
CA2411732A1 (en) 2001-09-20
AU746664B2 (en) 2002-05-02
CN1680350A (zh) 2005-10-12
HRP20020756A2 (en) 2004-12-31
PT1169314E (pt) 2002-11-29
IES20010109A2 (en) 2002-02-20
CA2360287C (en) 2003-09-09
FI109022B (fi) 2002-05-15
GB2357762B (en) 2002-01-30
SE0103046D0 (sv) 2001-09-14
NO20020356L (no) 2001-09-14
US20060247451A1 (en) 2006-11-02
SE0103046L (sv) 2001-11-14
DE60100022T3 (de) 2011-11-17
SE526022C2 (sv) 2005-06-14
CN1429220A (zh) 2003-07-09
SE517136C2 (sv) 2002-04-16
PL360158A1 (en) 2004-09-06
FI20010225A (fi) 2001-09-14
IS5841A (is) 2001-09-14
GB0105982D0 (en) 2001-05-02
TR200202185T2 (tr) 2002-12-23
CZ292077B6 (cs) 2003-07-16
ES2159491B1 (es) 2002-05-01
CH691537A5 (de) 2001-08-15
SK285528B6 (sk) 2007-03-01
EP1169314B2 (en) 2011-06-01
GB0102797D0 (en) 2001-03-21
EP1169314B1 (en) 2002-09-04
EP1227088A1 (en) 2002-07-31
DK1227088T3 (da) 2003-12-22
SE0200730D0 (sv) 2002-03-12
FI20010225A0 (fi) 2001-02-07

Similar Documents

Publication Publication Date Title
EA200200972A1 (ru) Кристаллическое основание циталопрама
AR018204A1 (es) METODO PARA LA PREPARACIOON DE CITALOPRAM , INTERMEDIARIO PARA LA PREPARACION DE CITALOPRAM Y EL USO DEL INTERMEDIARIO PARA LA PREPARACIoN DE CITALOPRAM
HUP0300078A2 (en) Method for the preparation of citalopram
EA200300279A1 (ru) Способ получения циталопрама
HUP0103417A2 (hu) Eljárás citalopram előállítására
EA200101232A1 (ru) Соединения феноксипропиламина
EA200400491A1 (ru) Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции
HUP0104856A2 (hu) Eljárás 5-cianoftalid előállítására
HUP0401451A2 (hu) Eljárás escitalopram elõállítására
BG66086B1 (bg) Кристална база на есциталопрам, негови соли и метод за получаване
CY1112937T1 (el) Μεθοδος για την παρασκευη ρακεμικης διολης σιταλοπραμης ή/και διολων s- ή r- σιταλοπραμης και η χρηση τετοιων διολων για την παρασκευη ρακεμικης σιταλοπραμης, r-σιταλοπραμης ή/και s-σιταλοπραμης
EA200501046A1 (ru) Эсциталопрамгидробромид и способ его получения
EA200200728A1 (ru) Способ получения циталопрама
EA200200969A1 (ru) Способ получения циталопрама
NO20053312L (no) Benzofuranderivat.
HUP0301942A2 (hu) Eljárás citalopram elżállítására
TR200202195T2 (tr) 5-Yer değiştirmiş 1-(4-florofenil)-1,3- dihidroizobenzofuran'ın adım adım alkillenmesi
HUP0300178A2 (en) Method for the preparation of citalopram
HUP0300180A2 (en) Method for the preparation of citalopram
EA200201003A1 (ru) Аморфная модификация торасемида
MXPA04001030A (es) Proceso para la preparacion de isobenzofuranos 5-sustituidos.
EA200301133A1 (ru) Способ получения дифторбензилэпоксидов и промежуточные соединения
EA200300768A1 (ru) Фармацевтическая композиция, содержащая циталопрам
AR030909A1 (es) Metodo para la preparacion de 1-(4-fluorfenil)-1,3-dihidroisobenzofuran-5-carbonitrilo (citalopram), un intermediario y una composicion farmaceutica antidepresiva.